| abstract |
The invention relates to avilamycin derivatives, genetic engineering, biosynthetic methods for the production thereof, medicaments containing said compounds and the utilization of said compounds for the production of a medicament against infectious diseases. The invention also relates to the nucleic acids, proteins and gene clusters and corresponding cells connected to the production of said avilamycin derivatives. |